Munro E, Chan P, Patel M, Betteridge L, Gallagher K, Schachter M, Sever P, Wolfe J
Regional Vascular Unit, St. Mary's Hospital, London, United Kingdom.
J Vasc Surg. 1994 Sep;20(3):482-7. doi: 10.1016/0741-5214(94)90149-x.
The mechanisms whereby restenoses occur at discrete sites within the vasculature remain uncertain. We have recently reported that vascular smooth muscle cells (VSMC) derived from patients with graft stenoses are resistant to growth inhibition by heparin. In this study, we have examined whether VSMC proliferation rates and responses to inhibition by heparin vary according to the individual or the anatomic site of origin.
Long saphenous veins from seven patients were divided into proximal, middle, and distal portions, and VSMC were cultured separately from each. VSMC proliferation in response to 15% fetal calf serum +/- 100 micrograms/ml heparin was measured by counting triplicate samples at 0, 3, 7, 10, and 14 days. This experiment was repeated from the second to the sixth passage (n = 6) and for artery and vein pairs derived from four additional patients.
Differences between vein segment cultures of individual veins were found not to differ significantly from experimental error for either proliferation or heparin inhibition and were not altered by repeated passage (ANOVA). There were, however, significant differences in sensitivity to heparin inhibition between patients (p = 0.02) (ANOVA). There were no significant differences between paired samples of artery and vein for either proliferation or heparin inhibition (Mann-Whitney test).
VSMC growth characteristics reflect the individual patient and are maintained in cell culture.
血管系统内离散部位发生再狭窄的机制仍不明确。我们最近报道,来自移植血管狭窄患者的血管平滑肌细胞(VSMC)对肝素的生长抑制作用具有抗性。在本研究中,我们检测了VSMC的增殖速率以及对肝素抑制的反应是否因个体或起源的解剖部位而异。
将7例患者的大隐静脉分为近端、中段和远端部分,并分别从中培养VSMC。通过在第0、3、7、10和14天对一式三份样本进行计数,测量VSMC对15%胎牛血清±100微克/毫升肝素的增殖反应。该实验在第2代至第6代重复进行(n = 6),并对另外4例患者的动脉和静脉配对样本进行检测。
对于增殖或肝素抑制,单个静脉的静脉段培养物之间的差异与实验误差相比无显著差异,且不受传代次数的影响(方差分析)。然而,患者之间对肝素抑制的敏感性存在显著差异(p = 0.02)(方差分析)。对于增殖或肝素抑制,动脉和静脉的配对样本之间无显著差异(曼-惠特尼检验)。
VSMC的生长特性反映个体患者情况,并在细胞培养中得以维持。